(Q45711948)

15 December 2017

Anxiogenic-like action of centrally administered glucagon-like peptide-1 in a punished drinking test (English)

1 reference

15 December 2017

3

1 reference

15 December 2017

5

1 reference

15 December 2017

Wolfgang Sommer

2

0 references

author name string

Christian Möller

series ordinal

1

1 reference

PubMed ID

11853101

15 December 2017

Roberto Rimondini

series ordinal

4

1 reference

15 December 2017

1 January 2002

1 reference

Progress in Neuro-Psychopharmacology & Biological Psychiatry

15 December 2017

1 reference

15 December 2017

26

1 reference

15 December 2017

119-122

1 reference

15 December 2017

1

1 reference

The role of the amygdala in fear and anxiety

15 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900223-8

7 January 2021

Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900223-8

7 January 2021

An assessment of the elevated X-maze for studying anxiety and anxiety-modulating drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900223-8

7 January 2021

Neuropeptide Y: an overview of central distribution, functional aspects, and possible involvement in neuropsychiatric illnesses

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900223-8

7 January 2021

Corticotropin-releasing factor and neuropeptide Y: role in emotional integration

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900223-8

7 January 2021

Characterization of glucagon-like peptide-1-(7-36)amide in the hypothalamus

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900223-8

7 January 2021

Distribution of pre-pro-glucagon and glucagon-like peptide-1 receptor messenger RNAs in the rat central nervous system.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900223-8

7 January 2021

Decreased experimental anxiety and voluntary ethanol consumption in rats following central but not basolateral amygdala lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900223-8

7 January 2021

Anxiogenic-like action of galanin after intra-amygdala administration in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900223-8

7 January 2021

Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900223-8

7 January 2021

Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900223-8

7 January 2021

Expression of c-fos protein in brain: metabolic mapping at the cellular level

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900223-8

7 January 2021

A role for glucagon-like peptide-1 in the central regulation of feeding

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900223-8

7 January 2021

A simple and reliable conflict procedure for testing anti-anxiety agents

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900223-8

7 January 2021

Glucagon-like peptide-1 (7-36) amide administered into the third cerebroventricle inhibits water intake in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900223-8

7 January 2021

10.1016/S0278-5846(01)00223-8

Identifiers

DOI

1 reference

15 December 2017

1 reference

PubMed ID

11853101